SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Raises Price Target to $4

Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and raises the price target from $2 to $4.

· 03/17/2021 08:26
Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and raises the price target from $2 to $4.